


Advent France Biotechnology launches its second fund with a first close at €86M ($102M)

New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies

Advent France Biotechnology creates Thabor Therapeutics and finances its seed
